Lisa Coram
Psychiatry · West Bloomfield, MINPI 1215197926
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 238 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,280 and has fallen 86.6% since, to $171 in 2024. Among psychiatry clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $19.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$632
- Otsuka America Pharmaceutical, Inc.$625
- Teva Pharmaceuticals USA, Inc.$470
- AbbVie$456
- Takeda Pharmaceuticals U.S.A., Inc.$456
- Johnson & Johnson$398
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,44698%
- Education$802%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 32 | $632 |
| Otsuka America Pharmaceutical, Inc. | 31 | $625 |
| Teva Pharmaceuticals USA, Inc. | 24 | $470 |
| AbbVie(2 entities) | 29 | $456 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $456 |
| Johnson & Johnson | 14 | $398 |
| Lundbeck LLC | 25 | $390 |
| Sunovion Pharmaceuticals Inc. | 18 | $334 |
| Avanir Pharmaceuticals, Inc. | 5 | $104 |
| Shire North American Group Inc | 5 | $96 |
| Alkermes, Inc. | 5 | $93 |
| Neurocrine Biosciences, Inc. | 5 | $93 |
| Livanova USA, Inc. | 3 | $88 |
| Jazz Pharmaceuticals Inc. | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Neos Therapeutics, LP | 2 | $28 |
| Corium, LLC | 2 | $24 |
| Neuronetics, Inc. | 2 | $21 |
| Bausch Health US, LLC | 1 | $15 |
| Tris Pharma Inc | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,526 in reported general payments places this provider in the 90th percentile of 1,166 psychiatry providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dyanavel XrAmphetamine | 14 | $5,959 |
| Quetiapine Fumarate | 13 | $426 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $231 |
| Buspirone Hcl | 11 | $151 |
| Eszopiclone | 17 | $94 |
| Alprazolam | 24 | $73 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Tris Pharma IncDyanavel Xr | $14 | $5,95914 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,166 psychiatry providers in Michigan.
Other psychiatry in West Bloomfield
- Theodore RuzaWest Bloomfield$100K
- Lynne LyonsWest Bloomfield$24K
- Kathleen Fouche BrazzleWest Bloomfield$12K
- Andreas SidiropoulasDetroit$2.8M
- Welton WashingtonYpsilanti$1.4M
- Joel YoungRochester Hills$1.1M
- Manzar RajputMonroe$612K
- William GuySouthfield$562K
- Robert LagrouClarkston$267K
- Michael IngramBay City$255K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.